Oey Rosalie C, de Man Robert A, Erler Nicole S, Verbon Annelies, van Buuren Henk R
1Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
2Department of Biostatistics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
United European Gastroenterol J. 2018 May;6(4):614-621. doi: 10.1177/2050640617744456. Epub 2017 Nov 20.
Recent investigations suggest an increasing prevalence of Gram-positive and antibiotic-resistant bacteria causing spontaneous bacterial peritonitis (SBP), probably related to changes in antibiotic prescription patterns, in particular more widespread and long-term use of antibiotic prophylaxis with quinolones.
The primary objective of this study was to assess potential changes in the microbiology of SBP in two patient cohorts studied at a 10-year interval. Further aims were to study prognostic factors and outcome of SBP.
A retrospective double-cohort study, including all ascitic cultures from patients with cirrhosis obtained 2003-2005 and 2013-2014, was conducted.
In total 312 patients were included, 125 patients in the first and 187 patients in the second cohort. SBP was diagnosed in 132 of 840 analyzed ascitic fluid samples; 62 samples were culture positive. An increase of Gram-positive bacterial isolates was noted from 26% to 46% between cohorts ( = 0.122). The prevalence of multidrug-antibiotic-resistant pathogens increased from 25% to 32% ( = 0.350). Survival after SBP among the two cohorts was comparable.
This single-center study in the Netherlands found a modest but nonsignificant increase in the proportion of patients with SBP caused by Gram-positive bacteria and multidrug-antibiotic-resistant bacteria over a 10-year period. Our findings differ from reported data in other countries and suggest empiric antibiotic prophylaxis and treatment of SBP should be based on national and regional microbiological findings and resistance patterns.
近期调查表明,引起自发性细菌性腹膜炎(SBP)的革兰氏阳性菌和抗生素耐药菌的患病率呈上升趋势,这可能与抗生素处方模式的改变有关,尤其是喹诺酮类抗生素预防用药更为广泛和长期的使用。
本研究的主要目的是评估两个间隔10年研究的患者队列中SBP微生物学的潜在变化。进一步的目的是研究SBP的预后因素和结局。
进行了一项回顾性双队列研究,纳入了2003年至2005年以及2013年至2014年期间肝硬化患者的所有腹水培养样本。
共纳入312例患者,第一队列125例,第二队列187例。在840份分析的腹水样本中,132份诊断为SBP;62份培养阳性。队列间革兰氏阳性菌分离株从26%增加到46%(P = 0.122)。多重耐药病原体的患病率从25%增加到32%(P = 0.350)。两个队列中SBP后的生存率相当。
荷兰的这项单中心研究发现,在10年期间,由革兰氏阳性菌和多重耐药菌引起的SBP患者比例有适度但无显著增加。我们的研究结果与其他国家报告的数据不同,表明SBP的经验性抗生素预防和治疗应基于国家和地区的微生物学发现及耐药模式。